Compare CFND & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFND | GNTA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | | Italy |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 34.0M |
| IPO Year | 2025 | N/A |
| Metric | CFND | GNTA |
|---|---|---|
| Price | $3.76 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.8K | ★ 119.2K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.70 | $0.71 |
| 52 Week High | $9.67 | $10.00 |
| Indicator | CFND | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 32.73 | 41.80 |
| Support Level | N/A | $0.71 |
| Resistance Level | $5.09 | $1.70 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 14.81 | 43.00 |
C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.